ND-630
ND-630是一种乙酰辅酶A羧化酶 (ACC) 抑制剂,对人类ACC1和ACC2的IC50值分别为2.1和6.1 nM。
生物活性
ND-630(别名GS-0976、NDI-010976)是一种乙酰辅酶A羧化酶 (ACC) 抑制剂,对人类ACC1和ACC2的IC50值分别为2.1和6.1 nM。ND-630 inhibits ACC activity by interacting within the phosphopeptide-acceptor and dimerization site of the enzyme to prevent dimerization. ND-630 inhibits fatty acid synthesis with an EC50 of 66 nM in HepG2 cells without altering the total cell number, cellular protein concentration, and incorporation of acetate into cholesterol.
Chronical administration of ND-630 to rats with diet-induced obesity reduces hepatic steatosis, improves insulin sensitivity, reduces weight gain without affecting food intake, and favorably affects dyslipidemia. Chronical administration of ND-630 Zucker diabetic fatty rats, ND-630 reduces hepatic steatosis, improves glucose-stimulated insulin secretion, and reduces hemoglobin A1c (0.9% reduction). ND-630 exhibits an aqueous solubility of 594 μM and human and rat plasma protein binding of 98.5% and 98.6%, respectively.
不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)
小鼠 | 大鼠 | 兔 | 豚鼠 | 仓鼠 | 狗 | |
重量 (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
体表面积 (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km 系数 | 3 | 6 | 12 | 8 | 5 | 20 |
动物 A (mg/kg) = 动物 B (mg/kg) × | 动物 B的Km系数 |
动物 A的Km系数 |
例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。
化学数据
分子量 | 569.63 |
分子式 | C28H31N3O8S |
CAS号 | 1434635-54-7 |
纯度 | 99.84% |
溶解性(25°C) | DMSO: ≥ 40 mg/mL |
储存和运输条件 | 固体粉末: -20°C 冷藏长期储存 常温运输及临时存放 |
储备液配制
以下数据基于产品分子量,对于特殊产品,请参照COA中的储备液配制条件和说明进行操作。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.7555 mL | 8.7776 mL | 17.5553 mL |
5 mM | 0.3511 mL | 1.7555 mL | 3.5111 mL |
10 mM | 0.1756 mL | 0.8778 mL | 1.7555 mL |
仅供科研使用,不得用于临床检验及治疗使用!